From yeast to neurodegenerative diseases: Ten years of exploration of mitochondrial dynamic disorders;De la levure aux maladies neurodégénératives © Dix ans d'exploration des pathologies de la dynamique mitochondriale

Medecine/Sciences

Volumn 26, Issue 10, 2010, Pages 836-841

  Lenaers, Guy ^b   Amati Bonneau, Patrizia ^a   Delettre, Cécile ^b   Chevrollier, Arnaud ^a   Verny, Christophe ^a   Miléa, Dan ^a   Procaccio, Vincent ^a   Bonneau, Dominique ^a   Hamel, Christian ^b   Reynier, Pascal ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149259540     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20102610836     Document Type: Review

References (36)

1. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000 ; 26: 207-10.
2. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynaminrelated GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Mat Genet 2000 ; 26: 211-5.
3. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36:449-51.
4. Waterham HR, Koster J, Van Roermund CW, et al. A lethal defect of mitochondrial and peroxisomal fission. N Cng) Med 2007 ; 356:1736-41.
5. Baxter RV, Ben Othmane K, Rochelle JM, et al. Ganglioside-induced differentiation-associated protein1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 2002 ; 30:21-2.
6. Claramunt R, Pedrala L, Sevilla T, et al. Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet 2005 ; 42:358-65.
7. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol 1959 ; 164 (suppl 54) : 1-147.
8. Milea D, Sander B, Wegener M, et al. Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol 2010; 88: 342-6.
9. Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010 ; 133: 771-86.
10. Lenaers G, Reynier P, El Achoun G, et al. OPAl functions in mitochondria and dysfunctions in optic nerve. Int; Biochem Cell Biol 2009 ; 41:1866-74.
11. Ferré M, Amati-Bonneau P, Tourmen Y, et al. OPA1: an online database for OPAl mutations. Hum Mutât r 2005;25:423-8.
12. Sauvanet C, Arnauné-Pelloquin L, David C, et al. Mitochondrial morphology and dynamics: actors, mecanisms and functions. Med Sci (Paris) 2010 ; 26:823-9.
13. Chevrollier A, Guillet V, Loiseau D, et al. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol 2008 ; 63: 794-8.
14. Zanna C, Ghelli A, Porcelli AM, et al. OPAl mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008 ; 131: 352-67.
15. Amati-Bonneau P, Valentino ML, Reynier P, et al. OPAl mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes. Bram 2008 ; 131: 338-51.
16. Sarzi E, Rotig A. Instabilité du génome mitochondrial et pathologies associées. Med Sci (Paris) 2010 ; 26:171-6.
17. Alavi MV, Bette S, Schimpf S, et al. A splice site mutation in the murine OPAl gene features pathology of autosomal dominant optic atrophy. Brain 2007 ; 130:1029-42.
18. Davies VJ, Hollins AJ, Piechota MJ, et al. OPAl deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 2007; 16:1307-18.
19. Charcot JM, Marie P. Sur une forme particulière d'atrophie musculaire progressive souvent familiale débutant par les pieds et les jambes et atteignant plus tard les mains. Rev Med 1886 ; 6:97-138.
20. Tooth H. The peroneal type of progressive muscular atrophy. London : HK Lewis, 1886.
21. Zuchner S, De Jonghe P, Jordanova A, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 2006 ; 59: 276-81.
22. Cartoni R, Martinou JC. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. txp Neurol 2009 ; 218: 268-73.
23. Vallat JM, Ouvrier RA, Pollard JD, et al. Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations. J Neuropathol Cxp Neurol 2008 ; 67:1097-102.
24. Cartoni R, Arnaud E, Médard JJ, et al. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A. Brain 2010 ; 133:1460-9.
25. Misko A, Jiang S, Wegorzewska I, et al. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 2010 ; 30:4232-40.
26. Loiseau D, Chevrollier A, Verny C, et al. Mitochondrial Coupling Defect in Charcot-Marie-Tooth Type 2A disease. Ann Neurol 2007 ; 61: 315-23.
27. Chen H, Vermulst M, Wang YE, et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010 ; 141: 280-9.
28. Niemann A, Ruegg M, La Padula V, et al. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 2005; 170:1067-78.
29. Cassereau J, Chevrollier A, Gueguen N, et al. Mitochondrial complex I deficiency in GDAPl-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K). Neurogenetics 2009 ; 10:145-50.
30. Mai S, Klinkenberg M, Auburger G, et at. Decreased expression of Drpl and Fisl mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINKl. J Cell Sci 2010;123:917-26.
31. Yang Y, Ouyang Y, Yang L, et al. Pinkl regulates mitochondrial dynamics throught interaction with the fission/fusion machinery. Proc Natl Acad Sci USA 2008 ; 105: 7070-5.
32. Ziviani E, Tao RN, Whitworth AJ. Drosophila Parkin requires PINKl for mitochondrial translocation and ubiquinates mitofusin. Proc Natl Acad Sci USA 2010 ; 107: 5018-23.
33. Wang X, Su B, Siedlak SL, et al. Amyloid beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 2008 ; 105:19318-23.
34. Wang H, Lim PJ, Karbowski M, Monteiro MJ. Effects of overexpression of Huntington proteins on mitochondrial integrity. Hum Mol Genet 2008 ; 18: 737-52.
35. Fukui H, Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 2008 ; 31: 251-6.
36. Vallat JM, Funalot B. La maladie de Charcot-Marie-Tooth. Med Sci (Paris) 2010 ; 26:842-7.